ML
MYND Life Sciences develops novel psychedelic pharmaceuticals aimed at treating mental health disorders such as depression and anxiety. By utilizing advanced drug formulation techniques, the company seeks to enhance therapeutic efficacy and improve patient outcomes in the life sciences sector.
Updated 3 months ago
Funding
$1.6M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- MYND Life Sciences develops novel psychedelic pharmaceuticals aimed at treating mental health disorders such as depression and anxiety. By utilizing advanced drug formulation techniques, the company seeks to enhance therapeutic efficacy and improve patient outcomes in the life sciences sector.